EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

A Second Pathogenic Protein, PolyGN2C‐iso2, Reveals a Dual‐Protein Pathology in Neuronal Intranuclear Inclusion Disease

Kang Zhang, Wenhao Ma, Yi Zhou, Zhijie Wu, Pan Gao, Hongze Niu, Hongfei Tai iD, Tianyi Zhao, Zheyue Dong, Li Li, Yan Zhang, An Wang and 11 more

Advanced Science · 2026

DOI: 10.1002/advs.76702 ↗

At a glance

Journal article in Advanced Science, 2026. Written by Kang Zhang and 22 co-authors. Institution: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Major MEDLINE topics: Intranuclear Inclusion Bodies, Neurodegenerative Diseases. 37 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Beijing Yicheng Cooperation Development Public Welfare Fund, Chinese Institute for Brain Research, Beijing core grant and Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background

Neuronal intranuclear inclusion disease (NIID) pathogenesis has been strongly linked to uN2CpolyG translated from NOTCH2NLC transcript variant 1. However, emerging evidence suggests that NOTCH2NLC transcript variant 2 may also generate a disease‐relevant protein, PolyGN2C‐iso2, but isoform‐discriminating and antibody‐independent evidence remains incomplete.

Methods

We characterize the aggregation propensity of PolyGN2C‐iso2 in vitro, develop isoform‐discriminating monoclonal antibodies for its detection in patient tissues, and perform targeted proteomic analysis of laser‐microdissected p62‐positive lesion cells. An AAV‐mediated mouse model expressing PolyG(108×)N2C‐iso2 is generated to assess its pathogenic potential, followed by behavioral, imaging, histopathological, proteomic, and functional analyses.

Results

NOTCH2NLC transcript variant 2 generates a distinct protein, PolyGN2C‐iso2, which forms aggregates in vitro. Using developed monoclonal antibodies together with targeted proteomics, we provide evidence that PolyGN2C‐iso2 is present within the pathognomonic intranuclear inclusions in NIID patient tissues, where it co‐localizes with uN2CpolyG. The PolyG(108×)N2C‐iso2 mouse model recapitulates key pathological hallmarks of NIID, including white matter abnormalities and cognitive deficits not fully captured by previous models. Mechanistically, PolyGN2C‐iso2 expression is found to induce profound mitochondrial dysfunction.

Conclusions

Our findings support the possibility that NIID involves a dual‐protein pathogenic process involving both uN2CpolyG and PolyGN2C‐iso2, which may have implications for therapeutic strategies targeting NOTCH2NLC‐derived pathogenic proteins.

Subjects

MeSH terms (MEDLINE)

Intranuclear Inclusion BodiesNeurodegenerative DiseasesAnimalsMiceHumansDisease Models, AnimalProteomicsNeuronsProtein IsoformsNerve Tissue ProteinsIntercellular Signaling Peptides and Proteins

Author keywords

GGC repeat expansionNOTCH2NLCPolyGN2C‐iso2dual‐proteinopathymitochondrial dysfunctionneuronal intranuclear inclusion disease

Substances

NOTCH2NLC protein, humanProtein IsoformsNerve Tissue ProteinsIntercellular Signaling Peptides and Proteins

Authors and institutions

  • Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • GeneCradle Therapeutics lnc., Beijing, China.
  • Beijing Ruicy Institute of Gene Therapy for Rare Disease, Beijing, China.
  • Beijing University of Technology, Beijing, China.
  • Beijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Chinese Institute for Brain Research (CIBR), Beijing, China.

ORCID profiles: Hongfei Tai, Wang Sheng, Hua Pan, Zaiqiang Zhang

Funding

  • National Natural Science Foundation of China
  • Beijing Yicheng Cooperation Development Public Welfare Fund
  • Chinese Institute for Brain Research, Beijing core grant and Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
  • Beijing Talent Program, co-funded by Beijing Tiantan Hospital and the Chinese Institute for Brain Research, Beijing

Cite

APA

Zhang, K., Ma, W., Zhou, Y., Wu, Z., Gao, P., Niu, H., Tai, H., Zhao, T., Dong, Z., Li, L., Zhang, Y., Wang, A., Shen, S., Li, Y., Yu, S., Peng, Y., Sheng, W., Dong, X., Pan, H., …, & Zhang, Z. (2026). A Second Pathogenic Protein, PolyGN2C‐iso2, Reveals a Dual‐Protein Pathology in Neuronal Intranuclear Inclusion Disease. Advanced Science. https://doi.org/10.1002/advs.76702

Vancouver

Zhang K, Ma W, Zhou Y, Wu Z, Gao P, Niu H, et al. A Second Pathogenic Protein, PolyGN2C‐iso2, Reveals a Dual‐Protein Pathology in Neuronal Intranuclear Inclusion Disease. Advanced Science. 2026. doi:10.1002/advs.76702

BibTeX
@article{Zhang2026,
  author = {Zhang, Kang and Ma, Wenhao and Zhou, Yi and Wu, Zhijie and Gao, Pan and Niu, Hongze and Tai, Hongfei and Zhao, Tianyi and Dong, Zheyue and Li, Li and Zhang, Yan and Wang, An and Shen, Si and Li, Yueyang and Yu, Sifei and Peng, Yan and Sheng, Wang and Dong, Xiaoyan and Pan, Hua and Shi, Kaibin and Koziol, Magdalena J and Wu, Xiaobing and Zhang, Zaiqiang},
  title = {A Second Pathogenic Protein, PolyGN2C‐iso2, Reveals a Dual‐Protein Pathology in Neuronal Intranuclear Inclusion Disease},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76702}
}
Start for free →